Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection

Short treatment duration of ledipasvir/sofosbuvir (LDV/SOF) has been successfully used to treat hepatitis C virus (HCV) genotype 1 infection in treatment-naive noncirrhotic patients with viral loads (VLs) under 6 million IU/mL. However, this short duration has not been studied in renal transplant re...

Descripción completa

Detalles Bibliográficos
Autores principales: Husson, Jennifer S., Ravichandran, Bharath, Jonchhe, Srijana, Kottilil, Shyamasundaran, Wilson, Eleanor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2017
Materias:
Infectious Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828686/
https://www.ncbi.nlm.nih.gov/pubmed/29536030
http://dx.doi.org/10.1097/TXD.0000000000000744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828686/
https://www.ncbi.nlm.nih.gov/pubmed/29536030
http://dx.doi.org/10.1097/TXD.0000000000000744

Ejemplares similares